Literature DB >> 15935600

A sensitive assay of amoxicillin in mouse serum and broncho-alveolar lavage fluid by liquid-liquid extraction and reversed-phase HPLC.

Xiaoli Du1, Chonghua Li, Heather K Sun, Charles H Nightingale, David P Nicolau.   

Abstract

A sensitive and simple high-performance liquid chromatography (HPLC) method was developed and validated for the analysis of amoxicillin in mouse serum and broncho-alveolar lavage (BAL) fluid. One hundred microlitres of sample were needed for the assay. Sample processing was carried out with liquid-liquid extraction. Cefadroxil was used as an internal standard. The chromatographic separation was achieved on a C18 reversed-phase column with a mobile phase consisting of phosphate buffer, 1-octanesulphonic acid sodium salt and acetonitrile. The detection was conducted at 210 nm. The ranges of the standard curves were 0.2-20 and 0.05-5 microg/ml for serum and BAL samples, respectively. The recoveries of amoxicillin from serum and normal saline were 87 and 88%, respectively. The coefficients of variation were 1.78-6.13% for intra-day and 0.82-6.42% for inter-day analyses. The accuracy was within 100+/-6%. This method was successfully applied to analyze amoxicillin in mouse serum and BAL samples from a pharmacokinetic study.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15935600     DOI: 10.1016/j.jpba.2005.04.021

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  9 in total

1.  Lack of pharmacokinetic bioequivalence between generic and branded amoxicillin formulations. A post-marketing clinical study on healthy volunteers.

Authors:  Mario Del Tacca; Giuseppe Pasqualetti; Antonello Di Paolo; Agostino Virdis; Gabriele Massimetti; Giovanni Gori; Daniele Versari; Stefano Taddei; Corrado Blandizzi
Journal:  Br J Clin Pharmacol       Date:  2009-07       Impact factor: 4.335

2.  Meropenem penetration into epithelial lining fluid in mice and humans and delineation of exposure targets.

Authors:  G L Drusano; T P Lodise; D Melnick; W Liu; A Oliver; A Mena; B VanScoy; A Louie
Journal:  Antimicrob Agents Chemother       Date:  2011-05-16       Impact factor: 5.191

3.  Transfer and distribution of amoxicillin in the rat gastric mucosa and gastric juice and the effects of rabeprazole.

Authors:  Hai-lun Zheng; Yong-mei Hu; Jun-jun Bao; Jian-ming Xu
Journal:  Acta Pharmacol Sin       Date:  2010-03-22       Impact factor: 6.150

4.  Identifying exposure targets for treatment of staphylococcal pneumonia with ceftobiprole.

Authors:  Keith A Rodvold; David P Nicolau; Thomas P Lodise; Mohammed Khashab; Gary J Noel; James B Kahn; Mark Gotfried; Sara A Murray; Susan Nicholson; Somvadee Laohavaleeson; Pamela R Tessier; G L Drusano
Journal:  Antimicrob Agents Chemother       Date:  2009-05-18       Impact factor: 5.191

5.  Pharmacodynamic characterization of ceftobiprole in experimental pneumonia caused by phenotypically diverse Staphylococcus aureus strains.

Authors:  Somvadee Laohavaleeson; Pamela R Tessier; David P Nicolau
Journal:  Antimicrob Agents Chemother       Date:  2008-04-14       Impact factor: 5.191

6.  Pharmacodynamic profile of tigecycline against methicillin-resistant Staphylococcus aureus in an experimental pneumonia model.

Authors:  Pornpan Koomanachai; Jared L Crandon; Mary Anne Banevicius; Li Peng; David P Nicolau
Journal:  Antimicrob Agents Chemother       Date:  2009-09-08       Impact factor: 5.191

7.  Pharmacodynamics of levofloxacin in a murine pneumonia model of Pseudomonas aeruginosa infection: determination of epithelial lining fluid targets.

Authors:  Arnold Louie; Christine Fregeau; Weiguo Liu; Robert Kulawy; G L Drusano
Journal:  Antimicrob Agents Chemother       Date:  2009-04-13       Impact factor: 5.191

8.  Metabolic and metagenomic outcomes from early-life pulsed antibiotic treatment.

Authors:  Yael R Nobel; Laura M Cox; Francis F Kirigin; Nicholas A Bokulich; Shingo Yamanishi; Isabel Teitler; Jennifer Chung; Jiho Sohn; Cecily M Barber; David S Goldfarb; Kartik Raju; Sahar Abubucker; Yanjiao Zhou; Victoria E Ruiz; Huilin Li; Makedonka Mitreva; Alexander V Alekseyenko; George M Weinstock; Erica Sodergren; Martin J Blaser
Journal:  Nat Commun       Date:  2015-06-30       Impact factor: 14.919

9.  Long-Term Effects of Early-Life Antibiotic Exposure on Resistance to Subsequent Bacterial Infection.

Authors:  Claire Roubaud-Baudron; Victoria E Ruiz; Alexander M Swan; Bruce A Vallance; Ceren Ozkul; Zhiheng Pei; Jackie Li; Thomas W Battaglia; Guillermo I Perez-Perez; Martin J Blaser
Journal:  mBio       Date:  2019-12-24       Impact factor: 7.867

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.